Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2

Science

Volumn 302, Issue 5652, 2003, Pages 1972-1975

  Li, Muyang ^a   Brooks, Christopher L ^a   Wu Baer, Foon ^a   Chen, Delin ^a   Baer, Richard ^a   Gu, Wei ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIODEGRADATION; CELLS; PROTEINS;

NUCLEAR DEGRADATION;

BIOCHEMISTRY;

HYBRID PROTEIN; POLYUBIQUITIN; PROTEIN MDM2; PROTEIN P53; UBIQUITIN;

CHEMISTRY; MOLECULAR ANALYSIS; PROTEIN;

ARTICLE; CELL NUCLEUS; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; MONOUBIQUITINATION; POLYUBIQUITINATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN MODIFICATION; PROTEIN TRANSPORT; REGULATORY MECHANISM; UBIQUITINATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL LINE, TUMOR; CELL NUCLEUS; CELLS, CULTURED; CYTOPLASM; HUMANS; MICE; MICE, KNOCKOUT; MUTATION; NUCLEAR PROTEINS; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RECOMBINANT FUSION PROTEINS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN;

EID: 0348134742     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1091362     Document Type: Article

References (33)

1. B. Vogelstein, D. Lane, A. J. Levine, Nature 408, 307 (2000).
2. R. Honda, H. Tanaka, H. Yasuda, FEBS Lett. 420, 25 (1997).
3. Y. Haupt, R. Maya, A. Kazaz, M. Oren, Nature 387, 296 (1997).
4. M. H. Kubbutat, S. N. Jones, K. H. Vousden, Nature 387, 299 (1997).
5. S. Fang, J. P. Jensen, R. L. Ludwig, K. H. Vousden, A. M. Weissman, J. Biol. Chem. 275, 8945 (2000).
6. Z. Lai etal., J. Biol. Chem. 276, 31357 (2001).
7. S. D. Boyd, K. Y. Tsai, T. Jacks, Nature Cell Biol. 2, 563 (2000).
8. R. K. Geyer, Z. K. Yu, C. G. Maki, Nature Cell Biol. 2, S69 (2000).
9. D. A. Freedman, A. J. Levine, Mol. Cell Biol. 18, 7288 (1998).
10. J. M. Stommel. et al., EMBO J. 18, 1660 (1999).
11. M. A. Lohrum, D. B. Woods, R. L. Ludwig, E. Balint, K. H. Vousden, Mol. Cell Biol. 21, 8521 (2001).
12. J. Gu, L. Nie, D. Wiederschain, Z. M. Yuan, Mol. Cell Biol. 21, 8533 (2001).
13. M. Li, J. Luo, C. L. Brooks, W. Gu, J. Biol. Chem. 277, 50607 (2002).
14. M. S. Rodriguez, J. M. Desterro, S. Lain, D. P. Lane, R. T. Hay, Mol. Cell Biol. 20, 8458 (2000).
15. S. Nakamura, J. A. Roth, T. Mukhopadhyay, Mol. Cell Biol. 20, 9391 (2000).
16. C. A. Midgley et al., Oncogene 19, 2312 (2000).
17. S. Y. Fuchs, V. Adler, T. Buschmann, X. Wu, Z. Ronai, Oncogene 17, 2543 (1998).
18. D. P. Xirodimas, C. W. Stephen, D. P. Lane, Exp. Cell Res. 270, 66 (2001).
19. Materials and methods are available as supporting material on Science Online.
20. M. Li, C. L. Brooks, W. Gu, unpublished results.
21. J. Terrell, S. Shih, R. Dunn, L. Hicke, Mol. Cell 1, 193 (1998).
22. R. Lev Bar-Or et al., Proc. Natl. Acad. Sci. U.S.A. 97, 11250 (2000).
23. T. R. Shirangi, A. Zaika, U. M. Moll, FASEB J. 16, 420 (2002).
24. Z. K. Yu, R. K. Geyer, C. G. Maki, Oncogene 19, 5892 (2000).
25. C. Blattner, T. Hay, D. W. Meek, D. P. Lane, Mol. Cell Biol. 22, 6170 (2002).
26. K. Okamoto et al., Mol. Cell 9, 761 (2002).
27. J. M. Parant, G. Lozano, Hum. Mutat. 21, 321 (2003).
28. S. R. Grossman et al., Science 300, 342 (2003).
29. C. M. Pickart, Annu. Rev. Biochem. 70, 503 (2001).
30. M. Li et al., Nature 416, 648 (2002).
31. R. P. Leng et al., Cell 112, 779 (2003).
32. A. Y. Nikolaev, M. Li, N. Puskas, J. Qin, W. Gu, Cell 112, 29 (2003).
33. We thank Z.-J. Chen for constructs and helpful discussions and Y.-P. Zhang for sharing unpublished data and critical suggestions. Supported by grants from the Avon Foundation, the Irma T. Hirschl Trust, and the National Institutes of Health/National Cancer Institute to W.G. and R.B. W.G. is a Leukemia & Lymphoma Society Scholar.